Holen Sie sich die Stockscreener-App
2.07
4.84%
-0.10
Finanzdaten der Pyxis Oncology Inc-Aktie (PYXS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
2.82
|
- | - | - | - |
Operating Expenses
|
1.50%
22.57
|
22.91 | 40.07 | 23.75 | 20.03 |
| Benefits Costs and Expenses |
1.26%
20.89
|
21.16 | 37.73 | 21.20 | 17.30 |
| Costs And Expenses |
1.26%
20.89
|
21.16 | 37.73 | 21.20 | 17.30 |
| Operating Income/Loss |
13.81%
-19.75
|
-22.91 | -40.07 | -23.75 | -20.03 |
| Nonoperating Income/Loss |
4.38%
1.679
|
1.756 | 2.334 | 2.551 | 2.731 |
| Income/Loss From Continuing Operations Before Tax |
14.59%
-18.07
|
-21.16 | -37.73 | -21.20 | -17.30 |
| Income Tax Expense/Benefit |
0.283
|
- | -2.164 | - | - |
| Income/Loss From Continuing Operations After Tax |
13.25%
-18.35
|
-21.16 | -35.57 | -21.20 | -17.30 |
|
Net Income/Loss
|
13.25%
-18.35
|
-21.16 | -35.57 | -21.20 | -17.30 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.42%
61.92
|
61.05 | 0.9338 | 60.72 | 60.50 |
| Diluted Average Shares |
1.42%
61.92
|
61.05 | 0.9338 | 60.72 | 60.50 |
| Basic Earnings Per Share |
14.29%
-0.30
|
-0.35 | -0.59 | -0.35 | -0.29 |
| Diluted Earnings Per Share |
14.29%
-0.30
|
-0.35 | -0.59 | -0.35 | -0.29 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):